Spots Global Cancer Trial Database for undifferentiated sarcoma
Every month we try and update this database with for undifferentiated sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| A Study of Nivolumab in Selected Uterine Cancer Patients | NCT03241745 | Uterine Cancer Endometrial Car... Carcinosarcoma Leiomyosarcoma Undifferentiate... High Grade Endo... Clear Cell Carc... | Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Lurbinectedin in FET-Fused Tumors | NCT05918640 | Ewing Sarcoma Desmoplastic Sm... Pediatric Cance... Undifferentiate... | Lurbinectedin | 10 Years - | Children's Hospital of Philadelphia | |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma | NCT04995003 | Sarcoma HER-2 Protein O... Osteosarcoma Rhabdomyosarcom... Ewing Sarcoma Synovial Sarcom... Soft Tissue Sar... Undifferentiate... | T cells or CAR ... Pembrolizumab I... Nivolumab Injec... | 1 Year - 25 Years | Baylor College of Medicine | |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma | NCT04995003 | Sarcoma HER-2 Protein O... Osteosarcoma Rhabdomyosarcom... Ewing Sarcoma Synovial Sarcom... Soft Tissue Sar... Undifferentiate... | T cells or CAR ... Pembrolizumab I... Nivolumab Injec... | 1 Year - 25 Years | Baylor College of Medicine | |
| A Study of Nivolumab in Selected Uterine Cancer Patients | NCT03241745 | Uterine Cancer Endometrial Car... Carcinosarcoma Leiomyosarcoma Undifferentiate... High Grade Endo... Clear Cell Carc... | Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma | NCT00876031 | Soft Tissue Sar... | trofosfamide, i... | 6 Months - 21 Years | University Hospital Tuebingen | |
| Lurbinectedin in FET-Fused Tumors | NCT05918640 | Ewing Sarcoma Desmoplastic Sm... Pediatric Cance... Undifferentiate... | Lurbinectedin | 10 Years - | Children's Hospital of Philadelphia | |
| Lurbinectedin in FET-Fused Tumors | NCT05918640 | Ewing Sarcoma Desmoplastic Sm... Pediatric Cance... Undifferentiate... | Lurbinectedin | 10 Years - | Children's Hospital of Philadelphia | |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
